These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18093410)

  • 1. The SCORE model in the POWER study: an attempt to focus the limited resources for prevention on patients with greatest need.
    De Backer G
    Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S19-24. PubMed ID: 18093410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
    Ruilope LM; Segura J
    Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It is likely that the risk of cardiovascular events from pharmaceuticals as COX-2 inhibitors can be reduced significantly by standard pharmaceutical and lifestyle preventative measures.
    Hellstrom HR
    Med Hypotheses; 2006; 67(6):1333-7. PubMed ID: 16814480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of total cardiovascular risk assessment in clinical practice.
    Graham IM
    Eur J Gen Pract; 2006; 12(4):148-55. PubMed ID: 17127600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive Cardiology: the SHAPE of the future. A Synopsis from the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M
    Herz; 2007 Aug; 32(5):356-61. PubMed ID: 17687524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and Framingham risk score for prediction of cardiovascular events in Caribbean Indian patients with blood glucose abnormalities.
    Jaquet A; Deloumeaux J; Dumoulin M; Bangou J; Donnet JP; Foucan L
    Diabetes Metab; 2008 Apr; 34(2):177-81. PubMed ID: 18353700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of cardiovascular diseases: collaborative program].
    Vértes A; Gyárfás I; Ofner P
    Orv Hetil; 2006 Oct; 147(39):1867-73. PubMed ID: 17111648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts.
    Giavarina D; Barzon E; Cigolini M; Mezzena G; Soffiati G
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):311-8. PubMed ID: 17434054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Model for estimation of cardiovascular risk in Norway].
    Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB
    Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional CVD risk factors and socio-economic deprivation in Roma minority population of Croatia.
    Zeljko H; Skarić-Jurić T; Narancic NS; Salihović MP; Klarić IM; Barbalić M; Starcević B; Lauc LB; Janićijević B
    Coll Antropol; 2008 Sep; 32(3):667-76. PubMed ID: 18982735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calibrating the SCORE cardiovascular risk chart for use in Spain].
    Sans S; Fitzgerald AP; Royo D; Conroy R; Graham I
    Rev Esp Cardiol; 2007 May; 60(5):476-85. PubMed ID: 17535758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China.
    Qin X; Jackson R; Marshall R; Lee L; Cao W; Zhan S; Hu Y
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):96-101. PubMed ID: 19237999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global preventive policies. Strategies at European and worldwide level.
    Kotseva K
    Rev Esp Cardiol; 2008 Sep; 61(9):960-70. PubMed ID: 18775238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk reduction: impact of an international project].
    Colle B; Brusaferro S;
    Ann Ig; 2008; 20(3 Suppl 1):43-8. PubMed ID: 18773604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overview of the scoring system for cardiovascular risk estimation: role and significance of lipids].
    Savić T; Tasić I; Janković D; Bojanić V; Janković I; Miladinović-Tasić N
    Med Pregl; 2009; 62 Suppl 3():24-32. PubMed ID: 19702112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first SHAPE (Screening for Heart Attack Prevention and Education) guideline.
    Naghavi M; Falk E; Hecht HS; Shah PK;
    Crit Pathw Cardiol; 2006 Dec; 5(4):187-90. PubMed ID: 18340236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary prevention of cardiovascular disease].
    Katić T; Sakić I; Bergovec M
    Acta Med Croatica; 2009 Feb; 63(1):71-4. PubMed ID: 19681467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.